Clearmind Medicine Inc. (CMND)

1.17

-0.04 (-3.31%)

At close: Mar 03, 2025, 3:58 PM

1.15

-1.96%

After-hours: Mar 03, 2025, 04:51 PM EST

Clearmind Medicine Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-5.25M	-6.23M	-9.41M	-3.9M	-233.22K	-105.28K	-194.53K	-6.67K
Depreciation & Amortization	51.07K	41.59K	113.38K	2.57K	179.69	n/a	n/a	n/a
Stock-Based Compensation	883.87K	366.4K	887.3K	500.24K	n/a	n/a	147.3K	n/a
Other Working Capital	-195.06K	-253.23K	441.42K	-317.61K	-23.79K	37.18K	-4.93K	-2.08K
Other Non-Cash Items	-512.7K	210.72K	836.94K	189.69K	28.00	-5.35K	-60K	371.00
Deferred Income Tax	103.88K	17.37K	40.75K	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-130.11K	-703.89K	1.69M	25.99K	-31.23K	42.28K	1.65K	-2.45K
Operating Cash Flow	-4.86M	-6.3M	-5.08M	-2.84M	-264.45K	-63.01K	-105.59K	-9.12K
Capital Expenditures	n/a	n/a	-7.59K	-231.19K	-10K	-10K	-131.17K	-18.42K
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-350.4K	n/a	n/a	-20K	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	78.5K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	33.8K	-26.23K	-7.59M	-14.65K	4.91K	n/a	n/a	n/a
Investing Cash Flow	-238.1K	-26.23K	-7.59K	-251.19K	-5.09K	-10K	-131.17K	-18.42K
Debt Repayment	-42.59K	-40.92K	-96.54	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	4.1M	438.01K	697.98M	n/a	-448.79K	n/a	-1.52K	130K
Financial Cash Flow	6.25M	8.43M	698.4K	7.36M	598.7K	n/a	208K	130K
Net Cash Flow	1.15M	3.83M	-4.42M	4.29M	329.15K	-73.01K	-28.76K	102.45K
Free Cash Flow	-4.86M	-6.3M	-5.09M	-3.07M	-274.45K	-73.01K	-236.76K	-27.55K